Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Gains from Investment Securities (2020 - 2025)

Tango Therapeutics has reported Gains from Investment Securities over the past 6 years, most recently at $19000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $19000.0 for Q4 2025, up 311.11% from a year ago — trailing twelve months through Dec 2025 was $19000.0 (up 575.0% YoY), and the annual figure for FY2025 was $5.3 million, down 73.1%.
  • Gains from Investment Securities for Q4 2025 was $19000.0 at Tango Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for TNGX hit a ceiling of $23.7 million in Q2 2025 and a floor of -$83000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $258669.5 (2021), compared with a mean of $4.9 million.
  • Biggest five-year swings in Gains from Investment Securities: soared 5033.27% in 2022 and later plummeted 800.0% in 2024.
  • Tango Therapeutics' Gains from Investment Securities stood at -$83000.0 in 2021, then soared by 924.1% to $684000.0 in 2022, then tumbled by 100.15% to -$1000.0 in 2023, then plummeted by 800.0% to -$9000.0 in 2024, then soared by 311.11% to $19000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $19000.0 (Q4 2025), $1.3 million (Q3 2025), and $23.7 million (Q2 2025) per Business Quant data.